Trabectedin
Trabectedin is listed in the FDA National Drug Code directory with 5 NDC codes, marketed under brand names including EVDI, YONDELIS. Available dosage forms: injection, solution, concentrate, injection, powder, lyophilized, for solution, powder.
Drug Details
- Generic Name
- Trabectedin
- Brand Names
- EVDI, YONDELIS
- Application Number
- NDA220837
- Sponsor
- Apotex Corp.
- NDC Codes
- 5
- Dosage Forms
- INJECTION, SOLUTION, CONCENTRATE, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, POWDER
- Routes
- INTRAVENOUS
- Active Ingredients
- TRABECTEDIN
Indications and Usage
1 INDICATIONS AND USAGE EVDI is indicated for the treatment of adult patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen [see Clinical Studies (14) ] . EVDI is an alkylating drug indicated for the treatment of adult patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen ( 1 )